https://www.selleckchem.com/pr....oducts/pyrrolidinedi
Some patients with hepatocellular carcinoma (HCC) are more likely to experience disease progression despite continuous transarterial chemoembolization (TACE), which is called TACE refractoriness. At present, it is still difficult to predict TACE refractoriness, although some models/scoring systems have been developed. At present, radiological-based radiomics models have been successfully applied to predict cancer patient prognosis. To develop and validate a computed tomography (CT)-based radiomics nom
Like
Comment
Share
